Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-16 · accession 0001839516-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-18 | 2025-12-16 | TARS | Whitfield Dianne C. | CHRO | S - Sale | $80.10 | -7,397 | 39.0K | -16% | -$592.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-16 | S | D | 7,397 | $80.10 | 38,958 | D | — | — |